Literature DB >> 1839059

Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solution.

M F Powell1, L M Sanders, A Rogerson, V Si.   

Abstract

The degradation of native LHRH in aqueous buffers of pH approximately 1-10 obeyed the rate equation, kobs = kH + alpha H+ + ko + kHO-(alpha HO-)x, where x at 60-100 degrees C was approximately 0.64 and temperature independent. Extrapolation to 25 degrees C using the Arrhenius equation and secondary rate constants showed that native LHRH is reasonably stable at pH 5.4, giving a shelf life (t90) of approximately 5 years. Regarding physical properties, hydrophobic LHRH analogues nafarelin and detirelix were found to be surface active as demonstrated by a decrease in apparent surface tension with increased peptide concentration. The CMC for detirelix at pH 7.4 was determined to be 5.3 x 10(-4) M (0.88 mg/ml), and that for nafarelin, greater than 2 mg/ml. At higher concentrations (approximately 4-8 mg/ml), nafarelin and detirelix formed nematic liquid crystals of undulose extinction (birefringence, less than 0.001). The thermodynamic stability of these peptide liquid crystals was probed by determining their melting points (Tcm) in the presence of propylene glycol, a solvent which proved to be efficacious at suppressing gelation and at destabilizing liquid crystals as measured by a reduction in Tcm.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839059     DOI: 10.1023/a:1015847628047

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  [Emulsions and water-surfactant-oil diagrams. A system of water-Brijs 92 and 96-oil of vaseline. Effect of surfactant hydrophilicity].

Authors:  J P Treguier; I Lo; M Seiller; F Puisieux
Journal:  Pharm Acta Helv       Date:  1975

2.  High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution.

Authors:  R G Strickley; M Brandl; K W Chan; K Straub; L Gu
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

3.  Characterization of the solution degradation products of histrelin, a gonadotropin releasing hormone (LH/RH) agonist.

Authors:  A R Oyler; R E Naldi; J R Lloyd; D A Graden; C J Shaw; M L Cotter
Journal:  J Pharm Sci       Date:  1991-03       Impact factor: 3.534

4.  Thermal stability of a long-acting analogue of luteinizing hormone releasing hormone (D-trp6-pro9-NEt-LHRH).

Authors:  J Winterer; D Chatterji; F Comite; M H Decker; D L Loriaux; J F Gallelli; G B Cutler
Journal:  Contraception       Date:  1983-02       Impact factor: 3.375

5.  Some solution properties of pentagastrin and angiotensin: aggregation of pentagastrin.

Authors:  D Attwood; A T Florence; R Greig; G A Smail
Journal:  J Pharm Pharmacol       Date:  1974-11       Impact factor: 3.765

6.  Carrier solutions for low-level intravenous insulin infusion.

Authors:  E W Kraegen; L Lazarus; H Meler; L Campbell; Y O Chia
Journal:  Br Med J       Date:  1975-08-23

7.  Synthesis and biological activity of some very hydrophobic superagonist analogues of luteinizing hormone-releasing hormone.

Authors:  J J Nestor; T L Ho; R A Simpson; B L Horner; G H Jones; G I McRae; B H Vickery
Journal:  J Med Chem       Date:  1982-07       Impact factor: 7.446

8.  Liquid crystals in emulsions, creams, and gels containing ethoxylated sterols as surfactant.

Authors:  C Müller-Goymann
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

  8 in total
  3 in total

Review 1.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

2.  Pulmonary delivery of detirelix by intratracheal instillation and aerosol inhalation in the briefly anesthetized dog.

Authors:  D B Bennett; E Tyson; C A Nerenberg; S Mah; J S de Groot; Z Teitelbaum
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

3.  Effect of gelation on the chemical stability and conformation of leuprolide.

Authors:  M M Tan; C A Corley; C L Stevenson
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.